RJ Amato

Amato, R. ., , Zhang, Y. ., Liu, W. ., Saxena, S. ., Shah, P. ., … Davis, D. . (2013). Epithelial cell adhesion molecule-positive circulating tumor cells as predictive biomarker in patients with prostate cancer. Urology, 81(6), 1303-7. https://doi.org/10.1016/j.urology.2012.10.041

Amato, R. ., Saxena, S. ., & Stepankiw, M. . (2013). Phase II trial assessing granulocyte-macrophage-colony stimulating factor, ketoconazole plus mitoxantrone in metastatic castration-resistant prostate cancer progressing after docetaxel treatments. Cancer Investigation, 31(3), 177-82. https://doi.org/10.3109/07357907.2013.764564

Amato, R. ., Shingler, W. ., Goonewardena, M. ., de Belin, J. ., Naylor, S. ., Jac, J. ., … Harrop, R. . (2009). Vaccination of renal cell cancer patients with modified vaccinia Ankara delivering the tumor antigen 5T4 (TroVax) alone or administered in combination with interferon-alpha (IFN-alpha): a phase 2 trial. Journal of Immunotherapy (Hagerstown, Md. : 1997), 32(7), 765-72. https://doi.org/10.1097/CJI.0b013e3181ace876